Drug and Device Development Outsourcing 2.0 - Soaring Beyond the CRO

January 9, 2023

ProPharma Group - the end-to-end, global provider of regulatory, clinical and compliance services for the pharmaceutical, biotechnology and medical device industries launched the Research Consulting Organization (RCO) model, a new type of research consulting and clinical service for biotech, pharma and device innovators to deliver bespoke solutions that bring life-saving drugs to market sooner and more cost effectively.


 

Download the Whitepaper

TAGS: Company News

Related Articles

Research Consulting Organization umbrella illustration
Press Releases

January 9, 2023

ProPharma Group launches revolutionary new operating model

$50m investment and rebrand unveiled at J.P. Morgan Healthcare Conference as part of new global growth strategy. RALEIGH, NC, January 9, 2023: ProPharma Group – the end-to-end, global provider of...

Continue reading the blog post
Multiple mobile devices with analytical data
Press Releases

May 9, 2023

ProPharma Announces Strategic Partnership with H1 to Optimize R&D with AI, Data Insights and Analytics

RALEIGH, NC, May 9, 2023, ProPharma Group (ProPharma), the world’s largest Research Consulting Organization (RCO) and a portfolio company of Odyssey Investment Partners, and H1, a leading healthcare...

Continue reading the blog post
View of ProPharma's new Headquarters in Raleigh, NC.
Press Releases

April 3, 2023

ProPharma Announces New Global Headquarters in Raleigh, NC as Hub for Innovation and Talent

RALEIGH, NC, April 3, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry and a portfolio company of Odyssey...

Continue reading the blog post